Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.85M | 12.61M | 11.94M | 11.76M | 10.02M | 8.92M |
Gross Profit | 7.89M | 7.99M | 6.48M | 6.27M | 5.31M | 3.51M |
EBITDA | 2.99M | 3.04M | 2.34M | 2.45M | 1.65M | 1.15M |
Net Income | 1.83M | 1.84M | 1.41M | 1.36M | 652.57K | 1.48M |
Balance Sheet | ||||||
Total Assets | 19.09M | 19.71M | 22.65M | 21.50M | 21.99M | 23.50M |
Cash, Cash Equivalents and Short-Term Investments | 4.49M | 4.70M | 5.73M | 5.34M | 3.88M | 4.06M |
Total Debt | 2.36M | 2.44M | 2.61M | 849.76K | 1.07M | 1.26M |
Total Liabilities | 17.77M | 18.26M | 19.86M | 19.64M | 21.17M | 23.35M |
Stockholders Equity | 1.31M | 1.45M | 2.78M | 1.86M | 819.23K | 154.88K |
Cash Flow | ||||||
Free Cash Flow | 2.20M | 2.44M | 1.19M | 1.63M | 80.07K | 396.54K |
Operating Cash Flow | 2.76M | 2.90M | 1.49M | 2.49M | 476.96K | 1.31M |
Investing Cash Flow | -481.00K | 727.00K | -1.33M | -863.19K | -396.89K | -909.85K |
Financing Cash Flow | -3.72M | -3.50M | -768.00K | -148.99K | -260.78K | -254.60K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | AU$36.36M | 19.87 | 87.09% | 2.68% | 1.86% | 16.10% | |
46 Neutral | C$194.28M | -4.22 | -8.60% | 2.64% | 13.54% | -1.44% | |
45 Neutral | AU$20.96M | ― | -51.49% | ― | 80.84% | 57.59% | |
45 Neutral | AU$42.42M | ― | -39.07% | ― | 26.07% | 0.85% | |
41 Neutral | AU$15.10M | ― | -71.10% | ― | ― | 76.17% | |
40 Neutral | AU$23.79M | ― | -104.23% | ― | ― | -17.26% | |
39 Underperform | AU$42.75M | ― | -33.42% | ― | 158.37% | 36.73% |
Cryosite Limited has announced a change in the director’s interest in securities. Mark Kerr, a director of the company, has acquired 75,000 fully paid ordinary shares through on-market purchases, increasing his total holdings. This acquisition reflects a continued investment by the director in the company, potentially signaling confidence in the company’s future performance.
Cryosite Limited announced a change in the director’s interest, with Mark Kerr acquiring an additional 231,453 fully paid ordinary shares, bringing his total to 7,231,453 shares. This change, conducted through both off-market and on-market trades, reflects a strategic move in the company’s governance structure, potentially impacting its market positioning and stakeholder interests.